Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

MERCK SHARP & DOHME LDA

NIF 500191360
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €18,049,939 158 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €18,049,939 158 contracts
A2 · Late Publication €38,895,866,275 5,116 contracts
Contract published to BASE more than 10 days after the signing date
LOW €38,895,866,275 5,116 contracts
A5 · Threshold Splitting €56,211,335 156 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €56,211,335 156 contracts
A6 · Low Competition €8,314,520 40 contracts
Only one bidder participated in a competitive procedure
MEDIUM €8,314,520 40 contracts
A9 · Price Overrun €225 1 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
HIGH €225 1 contracts
A9 · Abnormal Price Reduction €45,442,571,055 2,432 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €45,442,571,055 2,432 contracts
B5 · Benford's Law Deviation €10,614,025,036 2 contracts
Entity's contract values deviate from the Benford leading-digit distribution (chi-square goodness-of-fit, min 20 contracts). Score: 35 (p<0.05) or 55 (p<0.01).
MEDIUM €10,614,025,036 2 contracts
C3 · Missing Mandatory Fields €27,961,607 86 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €27,961,607 86 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

34
€11,122,355,109
670
€2,512,257,776
91
€1,233,772,691
124
€1,178,089,243
62
€1,162,542,914
95
€1,156,715,443
468
€1,108,080,016
54
€1,050,009,376
80
€1,039,910,866
182
€1,012,755,020
219
€1,009,685,025
249
€1,007,826,847
114
€978,341,343
311
€972,647,453
380
€952,338,699
358
€937,362,050
48
€917,444,812
67
€909,898,846
35
€884,303,408
88
€804,611,977
Page 1 of 4 · 76 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Price Overrun A9 · Abnormal Price Reduction B5 · Benford's Law Deviation C3 · Missing Mandatory Fields

Page 1 of 1 · 1 contracts

Aquisição de Medicamentos do foro oncológico e imunomoduladores ao abrigo do CPA 2021-06 para o HFF para o ano 2021
PT · 7776776 · Ao abrigo de acordo-qu...
A9 · Price Overrun
€225 2021-07-28
Overview
Total Value Won
€45,905,468,352
Contracts Won
7,073
Score 245005 · CRITICAL RISK
NIF
500191360
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

No director data imported yet.

Director and fiscal identity data for Portuguese companies can be found in the Registo Comercial (publicacoes.mj.pt).

Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned